CoChat

The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity

Open access
Chen, Yuwen, Gao, Jie, Ma, Mingyue, Wang, Ke, Liu, Fangming, Yang, Feiyu, Zou, Xin, Cheng, Zhouli, Wu, Duojiao · 2024 · OncoImmunology

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

T cell immunity is critical for human defensive immune response. Exploring the key molecules during the process provides new targets for T cell-based immunotherapies. CMC1 is a mitochondrial electron transport chain (ETC) complex IV chaperon protein. By establishing in-vitro cell culture system and Cmc1 gene knock out mice, we evaluated the role of CMC1 in T cell activation and differentiation. The B16-OVA tumor model was used to test the possibility of targeting CMC1 for improving T cell anti-tumor immunity. We identified CMC1 as a positive regulator in CD8+T cells activation and terminal differentiation. Meanwhile, we found that CMC1 increasingly expressed in exhausted T (Tex) cells. Genetic lost of Cmc1 inhibits the development of CD8+T cell exhaustion in mice. Instead, deletion of Cmc1 in T cells prompts cells to differentiate into metabolically and functionally quiescent cells with increased memory-like features and tolerance to cell death upon repetitive or prolonged T cell receptor (TCR) stimulation. Further, the in-vitro mechanistic study revealed that environmental lactate enhances CMC1 expression by inducing USP7, mediated stabilization and de-ubiquitination of CMC1 protein, in which a mechanism we propose here that the lactate-enriched tumor microenvironment (TME) drives CD8+TILs dysfunction through CMC1 regulatory effects on T cells. Taken together, our study unraveled the novel role of CMC1 as a T cell regulator and its possibility to be utilized for anti-tumor immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/2162402x.2024.2344905

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. The expression of CMC1 associates with T cell activation and apoptosis.
Figure 1. The expression of CMC1 associates with T cell activation and apoptosis.CC BY-NC · PubMed Central
Figure 2. CMC1 accelerates CD8+Teff cells activation and apoptosis.
Figure 2. CMC1 accelerates CD8+Teff cells activation and apoptosis.CC BY-NC · PubMed Central
Figure 3. Cmc1-/- CD8+T cells retain more CD44+CD62L+Tm cells and survive longer upon secondary activation in vitro.
Figure 3. Cmc1-/- CD8+T cells retain more CD44+CD62L+Tm cells and survive longer upon secondary activation in vitro.CC BY-NC · PubMed Central
Figure 4. CMC1 deficiency attenuates CD8+T cells exhaustion-like development during chronic TCR stimulation.
Figure 4. CMC1 deficiency attenuates CD8+T cells exhaustion-like development during chronic TCR stimulation.CC BY-NC · PubMed Central
Figure 5. Lactate enhances CMC1 expression through USP7-mediated stabilization and de-ubiquitination of CMC1 protein.
Figure 5. Lactate enhances CMC1 expression through USP7-mediated stabilization and de-ubiquitination of CMC1 protein.CC BY-NC · PubMed Central
Figure 6. Tumor-bearing Cmc1-/- mice have more non-exhausted and progenitor exhausted CD8+TILs.
Figure 6. Tumor-bearing Cmc1-/- mice have more non-exhausted and progenitor exhausted CD8+TILs.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 20

Metadata

Authors
Chen, Y., Gao, J., Ma, M., Wang, K., Liu, F., Yang, F., Zou, X., Cheng, Z., & Wu, D.
Affiliations
  • Jinshan Hospital Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China
  • Fudan University (CN)
  • Shanghai Jiao Tong University (CN)
  • Jinshan Hospital of Fudan University (CN)
Corresponding author
Wu, Duojiao
Venue
OncoImmunology
Published
2024-04-23
Volume
13
Issue
1
Pages
2344905-2344905
ISSN
  • 2162-4011 (ISSN-L)
  • 2162-402X
OpenAlex
W4395031722
Cited by
13
References
53
Citations by year
2026: 6 · 2025: 6 · 2024: 1
FWCI
2.16
Type
journal article
Language
en
Open access
Locations
  • OncoImmunology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
the National Natural Science Foundation of China (82273188)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
T cell exhaustion, CD8+ T cells, USP7, deubiquitination, lactate, tumor microenvironment, T cell receptor stimulation, antitumor immunity, T cell-based immunotherapy
MeSH terms
Animals, Cell Differentiation, Lymphocyte Activation, Melanoma, Experimental, Mice, Inbred C57BL, Mice, Knockout, CD8-Positive T-Lymphocytes, Mitochondrial Proteins, Ubiquitin Thiolesterase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity. https://app.cochat.ai/papers/10.1080/2162402x.2024.2344905
The paper
Chen, Y., Gao, J., Ma, M., Wang, K., Liu, F., Yang, F., Zou, X., Cheng, Z., & Wu, D. (2024). The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity. OncoImmunology. https://doi.org/10.1080/2162402x.2024.2344905

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.